Ultrasound for Filler Complications: Use Cases, Training, and Documentation
How aesthetic practices use ultrasound for filler complications, including vascular occlusion, delayed nodules, migrated product, training limits, and documentation…
FDA clearances and approvals, off-label use, scope-of-practice rules, and how to read a 510(k) summary without trusting the marketing wrapper.
How aesthetic practices use ultrasound for filler complications, including vascular occlusion, delayed nodules, migrated product, training limits, and documentation…
Dermal filler can cause vision loss if material enters vessels linked to the eye. Learn the danger zones, mechanism, and what to ask before treatment.
Letybo is the newest FDA-approved neuromodulator in the U.S. Here is how it compares to Botox, Dysport, and Xeomin on onset, duration, unit conversion, cost, and patient…
Daxxify lasts longer but costs more per session. Dysport spreads wider and kicks in faster. A head-to-head comparison of two botulinum toxin A products that serve…
Vascular occlusion from filler can cause skin necrosis, blindness, or stroke. Incidence is rising. How to recognize it, how providers respond, and what to ask before any…
Alexandrite, diode, Nd:YAG, and IPL each suit different skin tones and hair types. Here is how laser hair removal works, which device you need, and what permanent hair…
Dysport is faster and spreads wider. Xeomin is the only naked toxin without complexing proteins. Both FDA-approved for glabellar lines. Here is how they actually differ.
Exosomes are applied after laser to speed recovery, but no product is FDA-approved and the clinical evidence is early-stage. Here is what patients should actually know.
Paradoxical adipose hyperplasia after CoolSculpting is rarer than manufacturers report. A 2025 meta-analysis found incidence 6.67x higher than stated. Covers PAH signs,…
Hyaluronidase dissolves HA filler but also breaks down your own HA, can trigger allergies, and works best with ultrasound guidance. When to dissolve, when to wait, and…